110 related articles for article (PubMed ID: 15203605)
1. Misleading CA-125 levels and computed tomography images in an endometrial cancer patient.
Tjalma WA
J Obstet Gynaecol; 2004 Jun; 24(4):470-1. PubMed ID: 15203605
[No Abstract] [Full Text] [Related]
2. Predictive factors for prolonged survival in recurrent endometrial carcinoma: Implications for follow-up protocol.
Otsuka I; Uno M; Wakabayashi A; Kameda S; Udagawa H; Kubota T
Gynecol Oncol; 2010 Dec; 119(3):506-10. PubMed ID: 20837356
[TBL] [Abstract][Full Text] [Related]
3. [Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Wang Q; Hong L; Wang JL; Yue MG; Li HB; Li Y
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):300-3. PubMed ID: 20510085
[TBL] [Abstract][Full Text] [Related]
4. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125.
Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS
Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer during pregnancy: management strategies.
Eriksson AG; Fallaas Dahl G; Nesbakken AJ; Lund KV; Amant F
Int J Gynecol Cancer; 2019 Sep; 29(7):1221-1224. PubMed ID: 31434687
[No Abstract] [Full Text] [Related]
6. CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer.
Hoskins PJ; Le N; Correa R
Gynecol Oncol; 2011 Jan; 120(1):52-5. PubMed ID: 20947152
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used durıing surveillance.
Simsek SY; Serbetcioglu G; Alemdaroglu S; Yetkinel S; Durdag GD; Celik H
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):473-477. PubMed ID: 31212025
[TBL] [Abstract][Full Text] [Related]
8. Tertiary cytoreduction for recurrent endometrial cancer.
Bellati F; Papadia A; Gasparri ML; Scanagatta P; Carriero F; Beneditti Panici P; Raspagliesi F
Eur J Gynaecol Oncol; 2017; 38(1):132-134. PubMed ID: 29767882
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Endometrioid Adenocarcinoma of Endometrium With Bone Metastases.
Khoo ACH; Rashid NKA
Clin Nucl Med; 2017 Aug; 42(8):635-636. PubMed ID: 28481802
[TBL] [Abstract][Full Text] [Related]
10. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.
Erturk A; Korkmaz E; Arslantas Z; Bekdemir S; Erturk NK
Rev Assoc Med Bras (1992); 2024; 70(5):e20231115. PubMed ID: 38775501
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma.
Suh DH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):206-10. PubMed ID: 22445206
[TBL] [Abstract][Full Text] [Related]
12. [Histologic diagnosis of endometrial cancer].
Kaku T; Kawano Y; Hagiwara T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
[No Abstract] [Full Text] [Related]
13. Practice guidelines: uterine corpus--endometrial cancer. Society of Gynecologic Oncologists Medical Practice Committee.
Oncology (Williston Park); 1998 Jan; 12(1):122-6. PubMed ID: 9474591
[No Abstract] [Full Text] [Related]
14. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
15. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
16. [Diagnosis and differential diagnosis of uncommon malignant tumor cells in cervical cytology].
Guo HQ; Zhao H; Wang NP; Cao J; Pan QJ
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):855-6. PubMed ID: 18346363
[No Abstract] [Full Text] [Related]
17. Liposomal doxorubicin: a phase II trial.
Balbi G; Visconti S; Monteverde A; Manganaro MA; Cardone A
Acta Biomed; 2007 Dec; 78(3):210-3. PubMed ID: 18330081
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Endometrial Cancer Follow-up Protocols: Time to Change?
Lubrano A; Benito V; Pinar B; Molano F; Leon L
Rev Bras Ginecol Obstet; 2021 Jan; 43(1):41-45. PubMed ID: 33513635
[TBL] [Abstract][Full Text] [Related]
19. The ability of helical CT to preoperatively stage endometrial carcinoma.
Hardesty LA; Sumkin JH; Hakim C; Johns C; Nath M
AJR Am J Roentgenol; 2001 Mar; 176(3):603-6. PubMed ID: 11222188
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study.
Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
